Here is how AnaptysBio, Inc. (ANAB) and Inspire Medical Systems (INSP) have performed compared to their sector so far this year. AnaptysBio (ANAB) has seen solid earnings estimate revision ...
In a report released on January 16, David Risinger from Leerink Partners maintained a Buy rating on AnaptysBio (ANAB – Research Report). The company’s shares closed last Friday at $15.85.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback